Annual report pursuant to Section 13 and 15(d)

STOCKHOLDER EQUITY (Details)

v3.22.1
STOCKHOLDER EQUITY (Details) - USD ($)
1 Months Ended 2 Months Ended 3 Months Ended 4 Months Ended 12 Months Ended 24 Months Ended
Aug. 14, 2021
Jul. 02, 2021
Jul. 01, 2021
Apr. 01, 2021
Aug. 28, 2020
Jul. 14, 2020
Jun. 24, 2020
May 20, 2020
Apr. 08, 2020
Mar. 31, 2020
Feb. 25, 2020
Jan. 09, 2013
Feb. 16, 2021
Jan. 31, 2021
Dec. 31, 2020
Mar. 30, 2022
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
STOCKHOLDER EQUITY (Details) [Line Items]                                          
Preferred Stock, Dividend Payment Terms           declared a dividend of one preferred share purchase right for each outstanding share of BioSig’s common stock to stockholders of record on July 27, 2020, and one right will be issued for each new share of common stock issued thereafter.                              
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)           $ 0.001                 $ 0.001   $ 0.001 $ 0.001 $ 0.001   $ 0.001
Preferred Stock, Redemption Price Per Share (in Dollars per share)           $ 50                              
Preferred Stock, Voting Rights           In the event that a person or group acquires beneficial ownership of 12% or more of BioSig’s then outstanding common stock, subject to certain exceptions, each right would entitle its holder (other than such person or members of such group) to purchase additional shares of BioSig’s common stock having a market value of two times the exercise price of the right. In addition, at any time after a person or group acquires 12% or more of BioSig’s outstanding common stock (unless such person or group acquires 50% or more), the Board may exchange one share of BioSig’s common stock for each outstanding right (other than rights owned by such person or group, which would have become void). The Rights Plan could make it more difficult for a third party to acquire control of BioSig or a large block of our common stock without the approval of our board of directors.                              
Preferred Stock, Shares Authorized                             1,000,000   1,000,000 1,000,000 1,000,000   1,000,000
Common Stock, Shares Authorized                             200,000,000   200,000,000 200,000,000 200,000,000   200,000,000
Common Stock, Par or Stated Value Per Share (in Dollars per share)                             $ 0.001   $ 0.001 $ 0.001 $ 0.001   $ 0.001
Common Stock, Shares, Issued                             30,764,792   30,764,792 35,567,180 30,764,792   30,764,792
Stock Issued During Period, Shares, Restricted Stock Award, Gross                                     219,334    
Stock Issued During Period, Shares, New Issues             2,187,500 1,068,550     2,500,000   251,720   83,055   424,357        
Proceeds from Issuance of Common Stock (in Dollars)             $ 16,161,980       $ 9,052,331         $ 3,000,000   $ 9,004,000 $ 25,215,000    
Payments of Debt Issuance Costs (in Dollars)             $ 1,338,020       $ 947,669                    
Stock Issued During Period, Shares, Issued for Services                           658,868              
Stock Issued During Period, Value, Issued for Services (in Dollars)                           $ 2,658,224       3,975,000 $ 4,400,000    
Class of Warrant or Rights, Exercised                                     580,487    
Proceeds from Warrant Exercises (in Dollars)                                   $ 0 $ 2,090,000    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period     550,000                             9,375 1,203,223    
Proceeds from Stock Options Exercised (in Dollars)                                   $ 28,000 $ 2,722,000    
Stock Issued During Period, Shares, Other     206,250                       83,055       83,055    
Payments of Stock Issuance Costs (in Dollars)               $ 93,425         $ 40,365       $ 222,397 $ 995,000      
At the Market Offering (in Dollars)         $ 45,000,000                                
Commission Rate                                 3.00%        
Stock Issued During Period, Value, New Issues (in Dollars)               $ 10,592,075         $ 1,300,135       $ 2,228,000   $ 25,215,000    
Stock Repurchased During Period, Shares                             80,958            
Shares Issued for Services [Member]                                          
STOCKHOLDER EQUITY (Details) [Line Items]                                          
Stock Issued During Period, Shares, Restricted Stock Award, Gross                   50,000                      
Stock Issued During Period, Shares, Issued for Services                                   1,124,341 679,555    
Stock Issued During Period, Value, Issued for Services (in Dollars)                                   $ 3,975,451 $ 4,399,533    
Shares Issued, Price Per Share (in Dollars per share)                             $ 6.47   $ 6.47   $ 6.47   $ 6.47
Stock in Exchange for Proceeds of Exercise of Warrants [Member]                                          
STOCKHOLDER EQUITY (Details) [Line Items]                                          
Class of Warrant or Rights, Exercised                                       542,646  
Proceeds from Warrant Exercises (in Dollars)                                       $ 2,088,997  
Exercise of Options [Member]                                          
STOCKHOLDER EQUITY (Details) [Line Items]                                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period                                   9,375   586,825  
Proceeds from Stock Options Exercised (in Dollars)                                   $ 27,750   $ 2,722,012  
Cashless Exercise of Warrants [Member]                                          
STOCKHOLDER EQUITY (Details) [Line Items]                                          
Class of Warrant or Rights, Exercised                                       37,841  
Stock Issued During Period, Shares, Other                                       12,840  
Cashless Exercise of Options [Member]                                          
STOCKHOLDER EQUITY (Details) [Line Items]                                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period                                       616,398  
Stock Issued During Period, Shares, Other                                       160,743  
Underwriting Agreement [Member]                                          
STOCKHOLDER EQUITY (Details) [Line Items]                                          
Stock Issued During Period, Shares, New Issues   2,500,000                                      
Proceeds from Issuance of Common Stock (in Dollars)   $ 9,004,033                                      
Payments of Stock Issuance Costs (in Dollars)   $ 995,966                                      
Restricted Stock Units (RSUs) [Member]                                          
STOCKHOLDER EQUITY (Details) [Line Items]                                          
Stock Issued During Period, Shares, Restricted Stock Award, Gross 50,000                                        
Stock Issued During Period, Shares, Other                                   258,084      
Viral Clear [Member]                                          
STOCKHOLDER EQUITY (Details) [Line Items]                                          
Stock Issued During Period, Shares, Restricted Stock Award, Gross       40,000                                  
Stock Issued During Period, Shares, New Issues                                         1,965,240
Shares Issued, Price Per Share (in Dollars per share)                 $ 0.001                        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period     550,000                             550,000      
Stock Issued During Period, Shares, Other     206,250           259,959           80,958       80,958    
Stock Issued During Period, Value, New Issues (in Dollars)                                         $ 15,600,000
Series E Preferred Stock [Member]                                          
STOCKHOLDER EQUITY (Details) [Line Items]                                          
Preferred Stock, Dividend Payment Terms           Each right will initially trade with common stock, and will allow its holder to purchase from BioSig one one-thousandth of a share of Series F Junior Participating Preferred stock, par value $0.001 per share, for an exercise price of $50.00, once the rights become exercisable.                              
Preferred Stock, Shares Authorized                             1,000   1,000 1,000 1,000   1,000
Series A Preferred Stock [Member]                                          
STOCKHOLDER EQUITY (Details) [Line Items]                                          
Preferred Stock, Shares Authorized                             200   200 200 200   200
Series B Preferred Stock [Member]                                          
STOCKHOLDER EQUITY (Details) [Line Items]                                          
Preferred Stock, Shares Authorized                             600   600 600 600   600
Series C Preferred Stock [Member]                                          
STOCKHOLDER EQUITY (Details) [Line Items]                                          
Preferred Stock, Dividend Payment Terms                       payable quarterly                  
Preferred Stock, Voting Rights                       The holders of the Series C Preferred Stock vote together with the holders of our common stock on an as-converted basis but may not vote the Series C Preferred Stock in excess of the beneficial ownership limitation of the Series C Preferred Stock. The beneficial ownership limitation is 4.99% of our then outstanding shares of common stock following such conversion or exercise, which may be increased to up to 9.99% of our then outstanding shares of common stock following such conversion or exercise upon the request of an individual holder.                  
Preferred Stock, Shares Authorized                             4,200   4,200 4,200 4,200   4,200
Series D Preferred Stock [Member]                                          
STOCKHOLDER EQUITY (Details) [Line Items]                                          
Preferred Stock, Shares Authorized                             1,400   1,400 1,400 1,400   1,400
Series F Preferred Stock [Member]                                          
STOCKHOLDER EQUITY (Details) [Line Items]                                          
Preferred Stock, Shares Authorized                             200,000   200,000 200,000 200,000   200,000
Viral Clear [Member]                                          
STOCKHOLDER EQUITY (Details) [Line Items]                                          
Stock Issued During Period, Shares, New Issues               1,068,550                          
Shares Issued, Price Per Share (in Dollars per share)               $ 10                          
Stock Issued During Period, Value, New Issues (in Dollars)               $ 10,592,075                          
Common Stock, Conversion Basis               each share of ViralClear common stock may be exchanged into 0.9 of a share our common stock if the ViralClear common stock subject to the share exchange was purchased in the August or September 2019 private placements, or 1.1 shares of our common stock if the ViralClear common